v3.26.3
Schedule of Segment Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Line Items]        
Revenue $ 13,942 $ 56,839
Cost of goods sold 4,334 11,877
Research and development 3,892,387 816,697 4,903,789 2,042,890
General and administrative 1,912,927   5,642,824  
Segment operating loss (5,795,706)   (10,501,651)  
Other income (expense), net (1,428,364) 9,019 (1,058,774) 30,070
Net loss (7,224,070) $ (2,288,034) (11,560,425) $ (6,069,866)
Reportable Geographical Components [Member]        
Segment Reporting [Line Items]        
Revenue 13,942   56,839  
Cost of goods sold 4,334   11,877  
Research and development 3,892,387   4,903,789  
General and administrative 506,438   2,068,495  
Segment operating loss (4,389,217)   (6,927,322)  
Other income (expense), net    
Net loss (4,389,217)   (6,927,322)  
Pharmaceutical Operations [Member] | Reportable Geographical Components [Member]        
Segment Reporting [Line Items]        
Revenue    
Cost of goods sold    
Research and development 3,892,387   4,903,789  
General and administrative 260,685   966,216  
Segment operating loss (4,153,072)   (5,870,005)  
Other income (expense), net    
Net loss (4,153,072)   (5,870,005)  
Premium Nutritional Supplements [Member] | Reportable Geographical Components [Member]        
Segment Reporting [Line Items]        
Revenue 13,942   56,839  
Cost of goods sold 4,334   11,877  
Research and development    
General and administrative 245,753   1,102,279  
Segment operating loss (236,145)   (1,057,317)  
Other income (expense), net    
Net loss (236,145)   (1,057,317)  
Corporate Segment and Other Operating Segment [Member] | Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]        
Segment Reporting [Line Items]        
Revenue    
Cost of goods sold    
Research and development    
General and administrative 1,406,489   3,574,329  
Segment operating loss (1,406,489)   (3,574,329)  
Other income (expense), net (1,428,364)   (1,058,774)  
Net loss $ (2,834,853)   $ (4,633,103)